Zachery Carter
HomeProductsFAQSign In
© 2026 Zachery Carter. All rights reserved.
ProductsFAQadmin@mypeptide.net(850) 384-0430Sign In
Legal
MyPeptide Privacy PolicyShipping and Returns PolicyMyPeptide Terms and Conditions
FDA DISCLAIMER

Statements made regarding our products have not been evaluated by the U.S. Food and Drug Administration. The efficacy of these products has not been confirmed by FDA-approved research. Products are not intended to diagnose, treat, cure, or prevent any disease. Information presented on this website is not a substitute for, or alternative to, information from a qualified health care practitioner. Please consult a licensed health care professional regarding any potential interactions or complications before using any product. This notice is required under the Federal Food, Drug, and Cosmetic Act.

HomeShopSign In

Researcher verification

MyPeptide sells research peptides exclusively to qualified researchers and laboratories for in vitro and laboratory use. Please confirm before continuing.

By proceeding you affirm the statements above are true. Products are not for human or veterinary use, not for use in diagnostic procedures, and have not been evaluated by the U.S. Food and Drug Administration.

© 2026 MyPeptide.net all rights reserved
Back to catalog
GLP-1
Metabolic Research
Research Use Only — Not for Human or Veterinarian Administration

GLP-1

GLP-1 (glucagon-like peptide-1) receptor agonist analogues are central to metabolic research, modulating incretin signaling, glucose-dependent insulin secretion, and gastric motility in laboratory models.

Select size

lyophilized
$95.00/ 10mg
Certificate of Analysis — GLP-1Certificate of AnalysisThird-party HPLC lab report · opens PDF

For laboratory and research use only. Not for human or veterinary use.

Mechanism of Action

GLP-1 analogues bind the GLP-1 receptor (GLP1R), activating cAMP/PKA pathways in pancreatic beta cells and central appetite-regulating circuits. Research focuses on receptor binding kinetics, downstream signaling, and metabolic endpoint assays.

Research Applications

  • Incretin pathway and GLP1R binding assays
  • Glucose homeostasis research models
  • Appetite and satiety signaling studies
  • Gastric emptying and GI motility research

Specifications

sequenceGLP-1 analogue (sequence varies by modification)
molecular WeightVaries by analogue (~3–4 kDa typical)
appearanceWhite lyophilized powder

Reconstitution (Laboratory)

Use bacteriostatic water under sterile laboratory conditions. Peptide concentration should be calculated per vial mass and verified against COA.

Storage & Handling

Lyophilized: stable for shipping at ambient temperature; long-term storage at 2–8 °C. Reconstituted: refrigerate immediately; minimize freeze-thaw cycles.

Quality Assurance

Every lot undergoes independent third-party HPLC purity analysis, mass spectrometry identity confirmation, and endotoxin testing (<0.5 EU/mg). Certificate of Analysis (COA) is stored against the SKU lot number and available through your research account portal.

Sources & References

  1. 1.Drucker DJ. Mechanisms of Action and Therapeutic Application of Glucagon-like Peptide-1. Cell Metab. 2018. · PubMed →
  2. 2.Holst JJ. The physiology of glucagon-like peptide 1. Physiol Rev. 2007. · PubMed →
  3. 3.Nauck MA, Meier JJ. GLP-1 receptor agonists in type 2 diabetes. Lancet Diabetes Endocrinol. 2021. · PubMed →